Zydus launches Topiramate extended-release capsules
Zydus is the first company to receive final approval and launch Topiramate extended-release capsules, USP 25 mg, 50 mg, and 100 mg…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
USFDA gives final nod to Zydus Lifesciences’ generic version of insomnia drug
The drug, triazolam, is used on a short-term basis to treat insomnia
Great Place To Work India announces India’s Best Workplaces in Pharmaceuticals, Healthcare and…
This year, 15 winners have been chosen
US FDA gives final approval to Zydus’s Acetaminophen injection
Acetaminophen injection is indicated to relieve mild-to-moderate pain, and to reduce fever
US FDA grants final approval to Zydus’s Micafungin for injection
Micafungin for injection is indicated to treat variety of fungal infections
Zydus receives final approval from the US FDA for Sildenafil for oral suspension
Sildenafil for oral suspension is used to treat high blood pressure in the lungs (pulmonary hypertension)
US FDA approves Mirabegron extended-release tablets by Zydus
Mirabegron is indicated for the treatment of Over Active Bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
Zydus launches Lenalidomide capsules
Lenalidomide is used to treat various types of cancers
Zydus receives tentative approval from the US FDA for Sugammadex Injection
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults…
Zydus Lifesciences and Lupin recall products in US
While Zydus Lifesciences is recalling products due to failed impurities/degradation specifications, Lupin is doing it due to CGMP…